Resultados de la búsqueda 151-160 of 11367 for Low testosterone

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... T-cell (CAR-T) therapy. The most common adverse event after CAR-T therapy is lower than normal blood cells (cytopenia) and up to one third of patients ...

2. Hematología - Ensayos clínicos - Mayo Clinic

   This is a peripheral blood Collection Protocol to study the T ... A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR- ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However, ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... T-cell (CAR-T) therapy. The most common adverse event after CAR-T therapy is lower than normal blood cells (cytopenia) and up to one third of patients ...

5. Médicos y departamentos

   Testosterone treatment of male hypogonadism. https://www.uptodate.com/contents/search. Accessed April 21, 2023. AskMayoExpert. Delayed male puberty. Mayo ...

6. Mayo Clinic Physician Update - April 2025

   Page 1.

7. Mayo Clinic Physician Update - December 2024

   Page 1.

8. Mayo Clinic Cardiovascular Physician Update - June 2024

   Page 1.

9. Médicos y departamentos

   Testosterone treatment of male hypogonadism. https://www.uptodate.com/contents/search. Accessed April 21, 2023. AskMayoExpert. Delayed male puberty. Mayo ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed death)-1 ...